Approval · Notice of Compliance 37880 · 2026
ODENSIFY: Notice of Compliance 37880
Issued July 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37880
- Date
- July 10, 2026
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- PROLIA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ODENSIFY | 02569787 | Approved |
Medicinal ingredients
- DENOSUMAB 60 MG per ML